BCM
RTO icon

Bayesian Capital Management’s Rentokil RTO Stock Holding History

Bayesian Capital Management’s Portfolio RTO Stock Details RTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,087
Closed -$485K – 1048
2024
Q1 		$485K Sell
16,087
-13,400
-45% -$372K 0.05% 445
2023
Q4 		$844K Buy
+29,487
New +$866K 0.09% 268
2023
Q2 		– Sell
-13,200
Closed -$482K – 1025
2023
Q1 		$482K Buy
+13,200
New +$417K 0.06% 401

Other funds holding RTO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
GCM
Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bayesian Capital Management's RTO Position: Q2 2024 in Review

Bayesian Capital Management sold out of Rentokil (RTO) in Q2 2024, closing a stake of 16,087 shares — an estimated $485K sold.

Bayesian Capital Management first reported a position in RTO in Q1 2023 and held it in 3 quarters. The position peaked at $844K in Q4 2023. 232 funds tracked by Wall St. Rank hold RTO as of Q2 2024.

  • Bayesian Capital Management reported no remaining Rentokil position as of Q2 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 16,087 Rentokil shares in Q2 2024, an estimated $485K.
  • Bayesian Capital Management first reported a position in Rentokil in Q1 2023 and held it in 3 quarters.
  • Bayesian Capital Management's Rentokil position peaked at $844K in Q4 2023.
  • 232 funds tracked by Wall St. Rank held Rentokil as of Q2 2024.

Based on Bayesian Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.